Project acronym: LIVERHOPE

Project full title: "Simvastatin and Rifaximin as new therapy for patients with decompensated cirrhosis"

News archive


arrow

LIVERHOPE 3rd Annual Meeting
19 October, 2020
Due to the coronavirus emergence, the meeting will be held via videoconference.

pdf Agenda
arrow

Position paper of the LIVERHOPE Consortium just published on Journal of Hepatology
04 September, 2020
Check it out here

arrow

The LIVERHOPE Nursing paper is now available in Hepatology journal
16 January, 2020
Check it out here

arrow

New videos available
January, 2020
Videos and Interviews section

arrow

LIVERHOPE 3rd Annual Meeting

20 March, 2020
Hospital Clinic - University of Barcelona, Barcelona

Due to the coronavirus emergence, the meeting planned for 20 March 2020 has been cancelled.

arrow

LIVERHOPE 2nd Annual Meeting

3 June, 2019
Centre Esther Koplowitz, Barcelona

arrow

Consensus Meeting about Clinical Trials in decompensated Cirrhosis

4 - 5 June, 2019
Girona

arrow

22 patients

June 2019 - 22 patients enrolled in the EFFICACY study


arrow

First patient included

January 2019 - the first patient included in the Efficacy Study in Hospital Clínic, Barcelona, Spain


arrow

27th Ed. International Congress “Trends and perspectives in hepatology"

30 November - 1 December 2018


At the international conference "Trends and Perspectives in Hepatology 2018" in Padova, Italy, Pere Ginès presented the LIVERHOPE project in the session "Targeting key pathogenic events in order to prevent cirrhosis progression"

arrow

LIVERHOPE first Annual Meeting

June 15, 2018 - Barcelona (TBA)


pdf Agenda
pdf Participant list
pdf Info

arrow

EASL Clinical Practice Guidelines

April 2018 - Announcement that 6 investigators from the LiverHope Consortium have participated in the committee that has prepared the EASL Clinical Practice Guidelines for management of patients with decompensated cirrhosis recently presented at the ILC 2018 in Paris and published in Journal of Hepatology

arrow

EASL ILC

April 2018 - The P.Is of the clinical centres met at the recent EASL ILC meeting in Paris to discuss the Efficacy trial

arrow

Datebase of the safety

April 2018 - The database of the safety trial has been closed

arrow

EASL ILC 2018

April 2018 - At EASL ILC 2018, Pere Ginès presented the LIVERHOPE in a EU Grant application session, the title of his talk was "How I did it"

arrow

45 patients

January 2018 - The recruitment period for the LIVERHOPE SAFETY study has been completed - 45 patients are currently eligible for analysis

arrow

40 patients

November 2017 - 40 patients (89%) validated for the Safety Study and are currently eligible for analysis

arrow

First two patients

August 2017 - the first two patients were enrolled in the Safety Study in the Hospital Clínic

arrow

LIVERHOPE

June 2017 - website online